BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aguilera-montilla N, Bailón E, Ugarte-berzal E, Uceda-castro R, Prieto-solano M, García-martínez E, Samaniego R, Van den Steen PE, Opdenakker G, García-marco JA, García-pardo A. Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells. Biochemical and Biophysical Research Communications 2019;520:198-204. [DOI: 10.1016/j.bbrc.2019.09.127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao F, Zhao C, Zhong F, Qin T, Li S, Liu J, Huang B, Wang X. Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia. PeerJ 2022;10:e12616. [PMID: 35111390 DOI: 10.7717/peerj.12616] [Reference Citation Analysis]
2 Larsson K, Höglund M, Larsson A, Thulin M, Karlsson T. Increased levels of the cardiovascular disease risk biomarkers GDF15 and myostatin in patients with chronic lymphocytic leukemia. Growth Factors 2020;38:189-96. [PMID: 34121574 DOI: 10.1080/08977194.2021.1932870] [Reference Citation Analysis]
3 Ma Y, Zhu MM, Yang M, Luo W, Ji LH. [Expression of MMP-9 and microvessels in rat organs with chronic mountain sickness]. Zhonghua Xue Ye Xue Za Zhi 2021;42:343-5. [PMID: 33979981 DOI: 10.3760/cma.j.issn.0253-2727.2021.04.013] [Reference Citation Analysis]
4 Banerjee S, Amin SA, Jha T. Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors. CCB 2021;15:19-49. [DOI: 10.2174/2212796815666210203104446] [Reference Citation Analysis]
5 Sidhu I, Barwe SP, Gopalakrishnapillai A. The extracellular matrix: A key player in the pathogenesis of hematologic malignancies. Blood Rev 2021;48:100787. [PMID: 33317863 DOI: 10.1016/j.blre.2020.100787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]